http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2599781-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_17e6c778a71c468773a533a0b4dcd1e8 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q17-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-1021 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0819 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-64 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-07 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08 |
| filingDate | 2010-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e2f0adcefbb51703fc30a261f49222b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_467b107b1848ebccd0c042f0de9e0010 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e58e4489065ee789edc09d38e040b9b |
| publicationDate | 2017-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2599781-T3 |
| titleOfInvention | Proteasome activating anti-aging peptides and compositions containing them |
| abstract | Peptide compound of the following general formula (I): R1 - X1 - X2 -Asp - Cys - Arg - X3 -X4 - (AA) p - R2 In which, X1 represents an aspartic acid, a glutamic acid, a serine, a threonine, or is equal to zero, X2 represents an arginine, a leucine, an isoleucine, or is equal to zero, X3 represents an arginine, a lysine, or is equal to zero, X4 represents an arginine, a proline, a histidine , a lysine, or equals zero, AA represents any amino acid except cysteine, or one of its derivatives, and p is an integer from 0 to 2, R1 represents the primary amine function of the N-terminal amino acid, free or substituted by a protecting group which can be selected from an acetyl group, a benzoyl group, a tosyl group or a benzyloxycarbonyl group, R2 represents the hydroxyl group of the carboxyl function of the C-terminal amino acid, free or substituted by a protecting group which can be selected from a C1 to C20 alkyl chain, or an NH2, NHY or NYY group in which Y represents a C1 to C4 alkyl chain, said sequence of general formula (I) being constituted by 3 to 9 amino acid residues, said sequence of general formula (I) being able to comprise substitutions of amino acids X1, X2, X3, and X4 by other chemically equivalent amino acids, where the EDCR peptide, Seq. is excluded. ID No. 119 of WO 2007131774. |
| priorityDate | 2009-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 229.